Treatment of Leishmaniasis With Impavido (Miltefosine): Higher-Weight Patient Registry

Trial Profile

Treatment of Leishmaniasis With Impavido (Miltefosine): Higher-Weight Patient Registry

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs Miltefosine (Primary)
  • Indications Leishmaniasis
  • Focus Therapeutic Use
  • Sponsors Knight Therapeutics
  • Most Recent Events

    • 28 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 05 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top